Stem is trading 5.11% up at $2.37, with no clear catalyst established in available coverage. - No new company-specific announcement explaining the November 3 move surfaced. - Stem announced a board strategic-alternatives review on October 26, not November 3. - Stem is scheduled to report third-quarter results after market close on November 5. The supplied market picture is mixed.